These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26530367)

  • 61. Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma.
    Yin L; He N; Chen C; Zhang N; Lin Y; Xia Q
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1908-1916. PubMed ID: 31072138
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Raman based hepatocellular carcinoma biomarker detection.
    Santiago-Cordoba MA; Romano PR; MacKay A; Demirel MC
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():3672-5. PubMed ID: 22255136
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ongoing challenges in the diagnosis of hepatocellular carcinoma.
    Terzi E; Salvatore V; Negrini G; Piscaglia F
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):451-63. PubMed ID: 26603785
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum TGF-β1: A Potential Biomarker for Early Detection of Hepatocellular Carcinoma.
    He J; Liu Y
    EBioMedicine; 2016 Oct; 12():4-5. PubMed ID: 27665049
    [No Abstract]   [Full Text] [Related]  

  • 65. The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome.
    Black AP; Mehta AS
    Curr Opin Pharmacol; 2018 Aug; 41():74-78. PubMed ID: 29772420
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Research progress of serum biomarkers for early screening of hepatocellular carcinoma].
    Zhu W; Huang Y
    Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):308-312. PubMed ID: 33979955
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma.
    Kotha S; Neong S; Patel K
    Expert Rev Mol Diagn; 2018 Aug; 18(8):713-722. PubMed ID: 30019978
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Should AFP (or any biomarkers) be used for HCC surveillance?
    Ahmed Mohammed HF; Roberts LR
    Curr Hepatol Rep; 2017 Jun; 16(2):137-145. PubMed ID: 29085770
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Update on biomarkers of hepatocellular carcinoma.
    Chaiteerakij R; Addissie BD; Roberts LR
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):237-45. PubMed ID: 24275343
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel, rapid, and sensitive homogeneous sandwich detection method of Glypican-3 as a serum marker for hepatocellular carcinoma.
    Han N; Wang W; Lu D; Wang H; Ma X; Fan X; Li F
    Chem Commun (Camb); 2017 Nov; 53(90):12209-12212. PubMed ID: 29077109
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Semi-quantitative measurement of a specific glycoform using a DNA-tagged antibody and lectin affinity chromatography for glyco-biomarker development.
    Lee JH; Cho CH; Kim SH; Kang JG; Yoo JS; Chang CL; Ko JH; Kim YS
    Mol Cell Proteomics; 2015 Mar; 14(3):782-95. PubMed ID: 25525205
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Epidemiology and risk factors of hepatocellular carcinoma].
    Budny A; Kozłowski P; Kamińska M; Jankiewicz M; Kolak A; Budny B; Budny W; Niemunis-Sawicka J; Szczypiór G; Kurniawka B; Burdan F
    Pol Merkur Lekarski; 2017 Sep; 43(255):133-139. PubMed ID: 28987047
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hope for a cure through earlier detection of hepatocellular cancer.
    Sitzmann JV
    Ann Surg Oncol; 1999 Mar; 6(2):133-4. PubMed ID: 10082034
    [No Abstract]   [Full Text] [Related]  

  • 75. Emerging evidence of molecular biomarkers in hepatocellular carcinoma.
    Umeda S; Kanda M; Kodera Y
    Histol Histopathol; 2018 Apr; 33(4):343-355. PubMed ID: 28959824
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Advances in liver fibrosis imaging and hepatocellular carcinoma: update in 2013. Preface.
    Kudo M
    Oncology; 2013; 84 Suppl 1():1-2. PubMed ID: 23428851
    [No Abstract]   [Full Text] [Related]  

  • 77. [Current global development of screening guidelines for hepatocellular carcinoma: a systematic review].
    Yang JC; Yu SQ; Gao L; Zhou QX; Zhan SY; Sun F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jul; 41(7):1126-1137. PubMed ID: 32741183
    [No Abstract]   [Full Text] [Related]  

  • 78. Candidate biomarkers for liver cancer.
    Cottingham K
    J Proteome Res; 2009 Feb; 8(2):428. PubMed ID: 19271311
    [No Abstract]   [Full Text] [Related]  

  • 79. Glycoproteomic Analysis of Urinary Extracellular Vesicles for Biomarkers of Hepatocellular Carcinoma.
    Li D; Jia S; Wang S; Hu L
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770959
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.